AstraZeneca PLC (AZN)
204.32
+2.08
(+1.03%)
USD |
NYSE |
Apr 14, 14:48
AstraZeneca Cash from Investing (TTM) : -7.111B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| GSK Plc | -7.740B |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Mereo BioPharma Group Plc | -0.02M |
| Moderna, Inc. | 1.946B |
| Abivax SA | -15.55M |